Stem Cell

Stem Cell

ICO Ended
13,111 Views
At SCI, we are devoted to the international research, development, and implementation of stem cell therapy. We are also expanding our network with professionals, labs, clinics, hospitals, and nonprofit organizations. Our ultimate goal at SCI is to connect people who need treatment with the right dedicated solutions and professionals for their unique needs. At SCI, we believe such connections should be convenient and at your fingertips, just as so many other services are in modern society. We imagine a world where each and every person, no matter where they come from, will be able to connect with a Stem Cel Specialist instantly through our Stem Cell Innovations application (SCI Application), and in the same connection be able to decide when and how much confidential information to share with professionals.
8.4
TOTAL SCORE
8.1
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 17 Sept 2018 - 09 Oct 2018
ICO Time: 21 Nov 2018 - 17 Jan 2019
Whitelist/KYC: KYC
Country: Gibraltar
Token info
Ticker: SCI
Platform: Ethereum
Token Type: ERC20
Available for sale: 800,000,000 SCI
Financial
ICO Price: 1 SCI = 0.15 USD
Accepting: BTC, ETH, LTC, Fiat
Soft cap: 3,000,000 USD
Hard cap: 36,000,000 USD
2013
Establishment of Camden RAD, LLC, a company devoted to stem cell research and development.
Q4 2017
Camden RAD, LLC is rebranded as Stem Cell Innovations, and a new company is established, based on blockchain technology.<br /> <br /> Advanced research begins to determine market and development opportunities.
Q1 2018
Attended Token 2049 conference in Hong Kong.<br /> <br /> Attended Stem Cell Summit at the University of California in Los Angeles (UCLA).<br /> <br /> Attended CBC conference in San Francisco, CA.<br />
Q2 2018
Attended ICO20 Summit in Santa Monica, CA.<br /> <br /> Integration of smart contract technology is established.<br /> <br /> Company headquarters incorporated in Gibraltar, GB.<br /> <br /> Strategic efforts toward development begins.<br /> <br /> Interviews with potential medical participants take place.
Q3 2018
Whitelist is scheduled to go live.<br /> <br /> Token Sale starts.
Q4 2018
Token Sale ends and min max caps are assessed.<br /> <br /> Distribution of Tokens to participants through ERC20 will commence.
Q1 2019
SCI will begin final testing and reporting based on blockchain technology being used.<br /> <br /> Creation of a non-identical patient identification factor on Passive Blockchain Node will be initialized.<br /> <br /> Demo testing for SCI Application v 1.0 will begin.
Q2 2019
Release of the SCI Application v1.1<br /> <br /> Enrollment begins for doctors, patients, and stem cell laboratories in the United States
Q3 2019
Release of Market Surveillance strategy for further growth<br /> <br /> Release SCI Application v2.0<br /> <br /> Enrollment begins for professionals, patients, and stem cell laboratories in Middle East and across North Africa.<br /> <br /> Announcement of first SCI Lab location and franchise expansion plan.
Q4 2019
Announcement of clinical development and research strategy in the stem cell field.<br /> <br /> Public announcement regarding SCI achievements to date.<br /> <br /> First ever online synthetic stem cell purchase through the SCI Application. Release SCI Application v3.0, fully functional platform for professionals and patients.
Q1 2020
Stem Cell Lab Evaluation report per first year of operation and development.<br /> <br /> Release SCI earnings and financials report.<br /> <br /> Release results of SCI's stem cell research and development to date.<br />
Q2 2020
Expansion of SCI stem cell labs and clinics in China, Japan, South Korea, and India.<br /> <br /> Begin charging membership fees (payable in Stem Cell Innovations tokens) for professional-facing portion of SCI application.
Q3 2020
Begin second phase of SCI stem cell research and development.<br /> <br /> Release SCI Application v3.5, including professional-facing component to help practitioners become more involved in the stem cell research space and contribute to the network.
Q4 2020
Expansion and acquisition of SCI stem cell labs and clinics in Europe.
Q1 2021
Release SCI earnings and financials report for second year operation and development.<br /> <br /> Release public update on SCI stem cell research and development.<br /> <br /> Stem Cell Lab Evaluation report for second year.
Q2 2021
Release SCI Application v4.0 including:<br /> <br /> A new platform for medical students, universities, and hospitals to engage with the SCI Application.<br /> <br /> Fully Functional EMR Worldwide Enforcing HIPPA and expanding of synthetic stem cell delivery to Latin America.
Screenshots taken on 13 Sep 2018
Moe Galal
Chief Executive Officer / Founder
Participates in a number of projects
Ben Barel
Chief Operations Officer / Co-Founder
Participates in a number of projects
Ali Alrashidi
Chief Technology Officer / Co-Founder
Participates in a number of projects
Matt Galal
Chief of Staff / Co-Founder
Participates in a number of projects
Kobi Barel
Operations Engineer / Co-Founder
Participates in a number of projects
John Glavinovich, M.D.
Medical Director
Participates in a number of projects
Philip Glukhovsky, D.C.
Health Informatics Manager
Participates in a number of projects
Roger Williams
VP of Marketing
Participates in a number of projects
Liz Curlett
VP, PR & Corporate Communications
Participates in a number of projects
Candice Kouchache
Business Development
Participates in a number of projects
Ahmed Elsantawi
VP of International Human Resources
Participates in a number of projects
David Marmon
Web Designer
Participates in a number of projects
Heather Deveaux
Copywriter
Participates in a number of projects
Everlecia Taylor
Creative Writer
Participates in a number of projects
Marina Evglevskaya
Administrative Manager
Participates in a number of projects
Rakel Apodaca
Product Manager
Participates in a number of projects
Michelle Chavon
Marketing
Participates in a number of projects

Advisors (7)

Boyan Josic
Participates in a number of projects
Marc X. Ellul
Participates in a number of projects
Roger Shortz, M.D.
Participates in a number of projects
Greg Maddex, D.O
Participates in a number of projects
Pantea Nakieen, M.D.
Participates in a number of projects
Shahab Sajadi
Participates in a number of projects
Igor Soshkin
Participates in a number of projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Pre-Sale
Shaft Foundation
SHAFT - 'Strategic Hub for AI-Focused Technology' is a team that has built ten-figure token projects, and some of the most widely used AI technologies. We are are already partnered with leaders in building AI agents for translation and accessibility. Speechlab is an initial partner part of AiFund Andrew Ngs incubator who founded Google Brain
Pre-Sale
OYOFI Finance
The Platform is one stop solution for integrated Crypto DeFi Ecosystem Viz–A-Viz staking, Swapping, Tokenisation of Real World Assets and use of crypto assets in real world through OYOFI debit and credit card.
Active
EASTER2025
$EASTER2025 is a vibrant, community-driven token designed to spread festive cheer across the crypto space. Celebrating every major holiday throughout the year, it unites investors and enthusiasts in a spirit of joy, innovation, and togetherness. Created by the community, for the community, EASTER2025 brings a unique seasonal twist to the world of digital assets, making every holiday a special occasion in the blockchain universe.
Active
Ozolio Token
Ozolio is a Live Streaming and Webcam Hosting platform that allows customers to broadcast their live content 24/7 to multiple locations, such as websites, social platforms, mobile apps etc. While customers focus on building community, trust, and brand awareness with their audience, Ozolio simplifies the complexities of live streaming and protects the customer’s live content. Ozolio is launching its ICO to fund the next evolution of live streaming, integrating AI-powered video analysis, real-time audience engagement, and blockchain-driven decentralization. Our platform enables businesses, content creators, and organizations to leverage high-quality, interactive, and monetizable live streams with unparalleled insights and automation. By investing in OZOT token, you gain access to exclusive benefits like discounted streaming services and premium features. With the global live streaming market expected to reach $520B by 2032, Ozolio is positioned to lead the industry’s transformation, creating new revenue opportunities for businesses while democratizing access to live content worldwide.
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Fan360
The first sports community for fans, that covers the complete fan experience. Follow your favourite sports star, club or brand and get rewarded for engaging.